Physician profile
Lawrence M Lee
NPI 1760740062
$20,944.79
in general payments reported to CMS, 2019-2025
54 companies · $2,332 in 2025
The $2,332 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,879 · 2020: $812 · 2021: $1,756 · 2022: $5,256 · 2023: $1,946 · 2024: $3,964 · 2025: $2,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,673 · Travel and Lodging: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,672.99 |
| Travel and Lodging | $1,568.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $6,353.04 | 2021-2025 | Interstim |
| Intuitive Surgical, INC. | $4,568.75 | 2019-2024 | Da Vinci Surgical System |
| Teleflex LLC | $1,347.73 | 2021-2025 | Urolift, Barrigel |
| Dendreon Pharmaceuticals LLC | $1,162.46 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $756.69 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Bayer Healthcare Pharmaceuticals INC. | $736.45 | 2019-2025 | |
| Pfizer INC. | $621.88 | 2019-2025 | |
| Boston Scientific Corporation | $416.62 | 2019-2025 | Rezum Generator, Axonics, Spaceoar System |
| Astellas Pharma US INC | $395.67 | 2019-2024 | Xtandi |
| Medtronic USA, INC. | $325.84 | 2019-2020 | |
| Bioprotect Medical, INC. | $293.67 | 2024-2025 | Bioprotect Balloon Implant System |
| Procept Biorobotics Corporation | $267.49 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $256.90 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $249.33 | 2019-2025 | Adstiladrin |
| Abbvie INC. | $219.60 | 2019-2025 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.